Downstream of Rac1, defects in the activity and localization of the p21-activated kinases (PAKs) have been observed in transgenic AD mouse models and resulted in cognitive impairments and dendritic spine alterations [58]. The gene discussed is RAC1; the disease is Alzheimer disease.